XML 43 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (8,401) $ (3,326) $ 0
Adjustments to reconcile net loss to net cash provided by operating activities:      
Management fee – related party 28 0 0
Performance participation interest – related party 3,280 0 0
Income (loss) from unconsolidated entities, net (3,148) 120 0
Depreciation and amortization 10,457 37 0
Share-based compensation 78 129 0
Straight-line rents (517) (11) 0
Amortization of below-market lease intangibles (195) 0 0
Amortization of above-market lease intangibles 26 0 0
Amortization of deferred financing costs 700 165 0
Unrealized loss (gain) on real estate-related securities, net 168 (5) 0
Distributions of earnings from investments in unconsolidated entities 1,830 0 0
Other operating activities 68 0 0
Change in assets and liabilities, net of assets and liabilities acquired in acquisitions:      
Increase in other assets (351) (60) 0
Increase in due to affiliates 4,503 3,433 0
Increase in accounts payable, accrued expenses and other liabilities 1,078 78 0
Net cash provided by operating activities 9,604 560 0
Cash flows from investing activities:      
Acquisitions of real estate (401,106) (66,718) 0
Investments in unconsolidated entities (29,630) (90,233) 0
Pre-acquisition deposits (3,390) 0 0
Capital improvements to real estate (2,758) 0 0
Purchase of real estate-related securities (14,079) (873) 0
Proceeds from sale of real estate-related securities 2,864 0 0
Distributions of capital from investments in unconsolidated entities 4,948 829 0
Net cash used in investing activities (443,151) (156,995) 0
Cash flows from financing activities:      
Proceeds from issuance of redeemable common stock 187,475 84,052 0
Repurchase of redeemable common stock (70,000) 0 0
Proceeds from issuance of common stock 111,986 9,025 200
Proceeds from issuance of preferred stock, net of offering costs 0 41 0
Subscriptions received in advance 250 0 0
Proceeds from revolving credit facility 135,500 67,700 0
Repayment of revolving credit facility (127,700) 0 0
Borrowings from mortgages payable 163,500 0 0
Borrowing from financing obligation 54,000 0 0
Payment of deferred financing costs (3,138) (605) 0
Contributions from non-controlling interests 4,127 0 0
Distributions to non-controlling interests (31) 0 0
Preferred stock dividends (8) (1) 0
Common stock distributions (10,633) (259) 0
Net cash provided by financing activities 445,328 159,953 200
Net change in cash and cash equivalents and restricted cash 11,781 3,518 200
Cash and cash equivalents and restricted cash, beginning of period 3,718 200 0
Cash and cash equivalents and restricted cash, end of period 15,499 3,718 200
Reconciliation of cash and cash equivalents and restricted cash to the consolidated balance sheets:      
Cash and cash equivalents 13,754 2,968 200
Restricted cash 1,745 750 0
Total cash and cash equivalents and restricted cash 15,499 3,718 200
Supplemental disclosures:      
Interest paid 1,743 50 0
Non-cash investing and financing activities:      
Unsettled trade payable 904 0 0
Assumption of assets and liabilities in conjunction with acquisitions of real estate, net 1,042 57 0
Accrued capital expenditures 492 0 0
Distributions payable 1,440 503 0
Accrued offering costs due to affiliates 3,313 931 0
Distribution reinvestment 107 0 0
Adjustment to carrying value of redeemable common stock $ 24,137 $ 0 $ 0